82
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Pharmacological therapy and blood pressure control in primary health care sites in China: data from 254,848 hypertensive patients

, , , , , , , , & show all
Pages 1467-1478 | Published online: 11 Oct 2018

References

  • JamesPAOparilSCarterBL2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)JAMA2014311550752024352797
  • ManciaGFagardRNarkiewiczK2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Eur Heart J201334282159221923771844
  • LakenMADawsonREngelmanOComparative effectiveness research in the “real” world: lessons learned in a study of treatment-resistant hypertensionJ Am Soc Hypertens2013719510123321408
  • National Health and Family Planning Commission of China2015 Statistical bulletin on medical and health institutions of China; 2015 Available from: http://www.nhfpc.gov.cn/mohwsbwstjxxzx/Accessed September 10, 2018 Chinese
  • ChenZLaunch of the health-care reform plan in ChinaLancet200937396721322132419376436
  • LiYYangLWangLBurden of hypertension in China: A nationally representative survey of 174,621 adultsInt J Cardiol201722751652327856040
  • LiuSWriting Group of 2010 Chinese Guidelines for the Management of Hypertension2010 Chinese guidelines for the management of hypertensionZhonghua Xin Xue Guan Bing Za Zhi2011397579615 Chinese22088239
  • National Health Ministry of China2011Norm of National Primary Public Health Services 2011 Available from: http://www.moh.gov.cn/jws/s3577/201105/51780.shtmlAccessed September 18, 2018 Chinese
  • Writing Group of Chinese Guidelines for blood pressure measurementsChinese Guidelines for blood pressure measurementsClin J Hypertens2011191211011115 Chinese
  • HalpernMTKhanZMSchmierJKRecommendations for evaluating compliance and persistence with hypertension therapy using retrospective dataHypertension20064761039104816651464
  • DeddensJAPetersenMRApproaches for estimating prevalence ratiosOccup Environ Med200865748150150618562687
  • LopezJMeierJCunninghamFSiegelDAntihypertensive medication use in the Department of Veterans Affairs: a national analysis of prescribing patterns from 2000 to 2002Am J Hypertens20041712 Pt 11095109915607614
  • WolfMHeutenHGde SwaefAde FalleurMVerpootenGAThe evolution of hypertension treatment in Belgium, a pharmacoepidemiological studyActa Cardiol201267214715222641971
  • LuJLuYWangXPrevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)Lancet2017390101122549255829102084
  • WuYWangZGaoRA survey on perception and knowledge of Chinese health care professionals in prevention and control of hypertensionChin J Cardiol2004323264269 Chinese
  • ZhangHZhangDLiJThe application of β-receptor blockers in patients with coronary heart disease in ChinaJ Chin Cardiol (China)2011276422425 Chinese
  • Committee on Hypertension, Chinese Medical Doctor AssociationGuidance and advices on β-receptor blockers in hypertensionChin J Frontiers Med Sci2013545866 Chinese
  • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research GroupThe Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA2002288232981299712479763
  • KuehleinTLauxGGutscherADiuretics for hypertension – an inconsistency in primary care prescribing behaviourCurr Med Res Opin201127349750221208153
  • LamersHJoosSGoetzKDiuretics for hypertension-reasons for a contradiction in primary care prescribing behavior: a qualitative studyJ Clin Hypertens20121410680685
  • SuMZhangQBaiXAvailability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional surveyLancet2017390101122559256829102087
  • GoASBaumanMAColeman KingSMAn effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and PreventionHypertension201463487888524243703
  • ChobanianAVBakrisGLBlackHRThe Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 reportJAMA2003289192560257212748199
  • JiangBLiuHRuXZhangHWuSWangWHypertension detection, management, control and associated factors among residents accessing community health services in BeijingSci Rep20144484524784167
  • DreyerNATunisSRBergerMOllendorfDMattoxPGliklichRWhy observational studies should be among the tools used in comparative effectiveness researchHealth Aff2010291018181825
  • SimITwo Ways of Knowing: Big Data and Evidence-Based MedicineAnn Intern Med2016164856256326809201
  • KhouryMJPlanning for the Future of Epidemiology in the Era of Big Data and Precision MedicineAm J Epidemiol20151821297797926628513
  • MooneySJWestreichDJEl-SayedAMCommentary: Epidemiology in the era of big dataEpidemiology201526339039425756221
  • XuHHouLZuoHAccuracy of pulse wave and oscillometric electronic sphygmomanometers for blood pressure measurements in obese peopleChin J Hypertens2017254338344 Chinese
  • WangZChenZZhangLStatus of Hypertension in China: Results From the China Hypertension Survey, 2012-2015Circulation2018137222344235629449338